UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C.  20549

 


FORM 8-K

 

CURRENT REPORT

Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

 

Date of Report (Date of earliest event reported): November 12, 2007

 

SYMMETRY MEDICAL INC.

(Exact name of Registrant as specified in its charter)

 


 

Delaware

333-116038

35-1996126

(State or other jurisdiction

(Commission File Number)

(IRS Employer

of incorporation)

 

Identification No.)

 

3724 N State Road 15, Warsaw, Indiana 46582

(Address of Principal executive offices, including Zip Code)

 

(574) 268-2252

(Registrant’s telephone number, including area code)

 

 

(Former name or former address, if changed since last report)

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):

o

 

Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

 

 

 

o

 

Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

 

 

 

o

 

Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

 

 

 

o

 

Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

 

 



Item 2.02.              Results of Operations and Financial Condition.

 

On November 12, 2007 the Company issued a press release containing an update of its accounting review at its Sheffield, UK operating unit, as previously disclosed in the Company’s Current Report on Form 8-K dated October 5, 2007. A copy of the press release is being furnished as Exhibit 99.1.

 

Item 9.01.              Financial Statements and Exhibits.

 

(d)           Exhibits

 

99.1                           “Symmetry Medical Provides Update of Previously Disclosed Accounting Review at Sheffield, UK Operating Unit” Press Release issued by Symmetry Medical Inc. dated November 12, 2007.

 

 

2



SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

 

Symmetry Medical Inc.

 

 

 

 

 

/s/ Fred L. Hite

 

Date: November 14, 2007

Name:  Fred L. Hite

 

 

Title:    Chief Financial Officer

 

 

 

 

 

 

3



EXHIBIT INDEX  

 

Exhibit
No.

 


Description

 

 

 

99.1

 

“Symmetry Medical Provides Update of Previously Disclosed Accounting Review at Sheffield, UK Operating Unit” Press Release issued by Symmetry Medical Inc. dated November 12, 2007.

 

 

4